@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-L74BL3RJ-1
  skos:prefLabel "Anabolic Agents"@en, "Anabolisants"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PRNPX325-3
  skos:prefLabel "Nandrolone"@fr, "Nandrolone"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-HT0Z5LC7-W .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-BBJDHV4W-1
  skos:prefLabel "Bone Density Conservation Agents"@en, "Agents de maintien de la densité osseuse"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HT0Z5LC7-W
  skos:hiddenLabel "Decadurabolin"@en, "Retabolyl"@en, "Retabolil"@en, "Decadurobolin"@en, "19-Nortestosterone Decanoate"@en, "19-nor-4-Androstene-17 beta-ol-3-one 17-decanoate"@en ;
  mesh:allowableQualifier jvr:-FWD2BGQ0-9, jvr:-BT300B3G-Q, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-THHNVC7V-3, jvr:-Q3979798-W, jvr:-W6SQV79N-S, jvr:-NFTHND7Q-8, jvr:-G4R176S9-J, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4, jvr:-D0F21513-5, jvr:-XV06LPML-W, jvr:-M63HSDM7-1, jvr:-CB30NGKB-3, jvr:-NB0XHT3S-N, jvr:-TJHVZCRZ-0, jvr:-NKM836P1-M, jvr:-R3QWLHRG-V, jvr:-S0CS1X5R-5, jvr:-WK5F724J-1, jvr:-T9HQD7ST-J, jvr:-R0ZCQ8X6-J, jvr:-H7K65Q8S-Z, jvr:-HQRFT0C6-B ;
  skos:altLabel "360-70-3 (Nandrolone Decanoate)"@en, "360-70-3 (Nandrolone Decanoate)"@fr, "H45187T098"@fr, "H45187T098"@en, "17 beta-Hydroxyestr-4-en-3-one 17-decanoate"@en ;
  mesh:pharmacologicalAction jvr:-L74BL3RJ-1, jvr:-BBJDHV4W-1 ;
  dc:created "2018-07-09"^^xsd:date ;
  a mesh:Descriptor, skos:Concept ;
  skos:definition "Decanoic acid ester of nandrolone that is used as an anabolic agent to prevent or treat WASTING SYNDROME associated with severe chronic illness or HIV infection (HIV WASTING SYNDROME). It may also be used in the treatment of POSTMENOPAUSAL OSTEOPOROSIS."@en ;
  skos:broader jvr:-PRNPX325-3 ;
  skos:inScheme jvr: ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D000077603> ;
  dc:established "2019-01-01"^^xsd:date ;
  skos:prefLabel "Nandrolone Decanoate"@en, "Décanoate de nandrolone"@fr ;
  dc:modified "2018-04-09"^^xsd:date .